p53 is an independent pre-treatment markers for long-term survival in stage II and III colorectal cancers: an analysis of interaction between genetic markers and fluorouracil-based adjuvant therapy
To access this article, please choose from the options below
PII: S0304-3835(04)00050-3
doi:10.1016/j.canlet.2004.01.006
© 2004 Elsevier Ireland Ltd. All rights reserved.
